LST1 Antikörper (FITC)
Kurzübersicht für LST1 Antikörper (FITC) (ABIN1401380)
Target
Alle LST1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LST1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LST1 (Leukocyte Specific Transcript 1 (LST1))
-
Andere Bezeichnung
- LST1
-
Hintergrund
-
Synonyms: B144, D6S49E, Leucocyte specic transcript 1, Leukocyte-specic transcript 1 protein, Liver Specic Transporter, LST 1, Lst1, LST1_HUMAN, Lymphocyte antigen 117, MGC119006, MGC119007, Protein B144.
Background: Possible role in modulating immune responses. Induces morphological changes including production of filopodia and microspikes when overexpressed in a variety of cell types and may be involved in dendritic cell maturation. Isoform 1 and isoform 2 have an inhibitory effect on lymphocyte proliferation.
-
Gen-ID
- 7940
Target
-